Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLOPIDOGREL BISULFATE USP (PROCESS-II), with a corresponding US DMF Number 30187.
Remarkably, this DMF maintains an Active status since its submission on February 15, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 01, 2016, and payment made on February 23, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II